[PDF][PDF] Sorafenib induces pyroptosis in macrophages and triggers natural killer cell–mediated cytotoxicity against hepatocellular carcinoma
C Hage, S Hoves, L Strauss, S Bissinger, Y Prinz… - …, 2019 - Wiley Online Library
Antiangiogenic and cytotoxic effects are considered the principal mechanisms of action of
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.
C Hage, S Hoves, L Strauss, S Bissinger… - Hepatology …, 2019 - europepmc.org
Antiangiogenic and cytotoxic effects are considered the principal mechanisms of action of
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma
C Hage, S Hoves, L Strauss… - Hepatology …, 2019 - pubmed.ncbi.nlm.nih.gov
Antiangiogenic and cytotoxic effects are considered the principal mechanisms of action of
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma
C Hage, S Hoves, L Strauss, S Bissinger, Y Prinz… - Hepatology, 2019 - cir.nii.ac.jp
抄録< jats: p> Antiangiogenic and cytotoxic effects are considered the principal mechanisms
of action of sorafenib, a multitarget kinase inhibitor approved for the treatment of …
of action of sorafenib, a multitarget kinase inhibitor approved for the treatment of …
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma
C Hage, S Hoves, L Strauss, S Bissinger, Y Prinz… - Hepatology, 2019 - journals.lww.com
Metabolic reprogramming endows cancer cells with the ability to adjust metabolic pathways
to support heterogeneously biological processes. However, it is not known how the …
to support heterogeneously biological processes. However, it is not known how the …
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma
C Hage, S Hoves, L Strauss, S Bissinger, Y Prinz… - Hepatology, 2019 - journals.lww.com
Antiangiogenic and cytotoxic effects are considered the principal mechanisms of action of
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …
sorafenib, a multitarget kinase inhibitor approved for the treatment of hepatocellular …